New GMP Guideline for Biopharmaceutical and Biotech-Based Products

The Korea Food and Drug Administration (KFDA) has recently completed a new administrative guideline for GMP (Good Manufacturing Practice) evaluation as specific to the domestic manufacturers of biopharmaceutical products, including vaccines and biotechnology-based treatments.

The KFDA expressed that its release of a new GMP evaluation guideline is reflective of an effort to enhance the quali...